Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

DAVID SMITH | America It’s Common Sense vs. Debt Slavery

David Smith of the Morgan Report sits down with Maurice Jackson of Proven and Probable to discuss a very important topic germane to the financial state of America, debt slavery. This interview addresses the various entities that are and have been creat...
Maurice Jackson | June 15, 2020 |

GlucoTrack: Company Addresses the Diabetes Testing and Monitoring Conundrum

GlucoTrack ( NDAQ:GCTK ) is an American medical device company focused on design, development and commercialization. The company is developing proprietary painless and non-invasive blood glucose monitoring devices for both Type 2 diabetes and prediabetes, a market almost ...
Simon Druker | January 16, 2023 |

Kiniksa Shares Trade Up 30% on COVID-19 Pneumonia and Hyperinflammation Treatment

Shares of Kiniksa Pharmaceuticals traded higher after the company reported early success in treatment response for mavrilimumab in six patients with severe COVID-19 pneumonia and hyperinflammation. This morning, Hamilton, Bermuda based biopharmaceutical comp...
Streetwise Reports | April 1, 2020 |

Gold Stocks Are Overbought. You Don’t Want Prices to Go Straight Up

Bill Powers of MiningStockEducation.com talks with a professional trader and market commentator Chris Vermeulen says gold stocks are overbought and need a breather which would be good for the overall upward trend. Chris shares how he has and is trading the junior gold ...
Chris Vermeulen | May 22, 2020 |

Implications for Gold – 2007-9 Great Recession vs. 2020 Coronavirus Crisis

When the economic crisis hits, the first instinct is to analyze the previous catastrophes to learn what to expect from and how to handle the current calamity. So, not surprisingly, many analysts have already pointed to the 2008 global financial crisis (GFC) as the most rel...
Arkadiusz Sieron | May 25, 2020 |

dynaCERT first institutional coverage; >250% near-term upside, no competition in $6 Trillion market

dynaCERT’s Fuel-Saving and Carbon Emission Reduction Technology is award winning and on an accelerated growth adoption curve that is expected to translate into significant sales and upside share price revaluation. dynaCERT's proprietary HG technology has ...
Fredrick William | September 24, 2019 |

Energy Company 'Still Surfing on the Guyana Wave' with New Oil Discovery

A Pareto Securities report addresses how the various joint venture wells of the firm derisk potential upside to its share price. In a Sept. 17 research note, analyst Tom Erik Kristiansen reported that Pareto Securities raised its target price on Eco Atlantic Oil & Ga...
Streetwise Reports | September 24, 2019 |

Achillion Pharma Shares Open 75% Higher After Alexion Buyout Offer

Shares of Achillion Pharmaceuticals are trading much higher today after the firm reported that it has agreed to be acquired by Alexion Pharmaceuticals for $930 million, or $6.30 per share in cash, along with the potential for an additional $2 per share if certain other specifi...
Streetwise Reports | October 17, 2019 |

Buzz on the Bullboards: A Fresh Start for Capital Markets in 2021?

(Image via Ivanhoe Mines Ltd.) The start of the new year marks a fresh beginning in the minds of many and 2021 holds an expectation that life will be better than the previous year, which will go down in infamy thanks to the global spread of the COVID-19 pandemic. Yo...
Stockhouse Editorial | January 6, 2021 |

Psychedelic Leader to Advance Mental Health in 2021 with Growth of Clinics, Lab and Partnerships

(Image via Numinus Wellness Inc.) In 2020, Health Canada began allowing select patients to take psilocybin for relief of end-of-life-distress. This was followed by a proposed regulation revision that could allow doctors to prescribe both psilocybin and MDMA for t...
Stockhouse Editorial | January 14, 2021 |
1 2 3